is 2.5 mg of tirzepatide effective Lilly launches lower-price weight-loss drug without injector pen Tirzepatide 2.5mg: Weight Loss Starter

Obesity, overweight cases among reasons US-based Max International has come to Kenya Audio By Vocalize Among its initiatives in Kenya will be to help people manage their weight, amidst growing cases of obesity in the country, and more so among those living in urban areas

Federal CMS rules may expand Medicaid anti-obesity coverage starting in mid-2026 if New York opts in

The report from Katz and colleagues comes less than a year after another report in the Journal of the American Medical Association suggested a link between semaglutide use and nonarteritic anterior ischemic optic neuropathy (NAION), which is a condition that causes sudden vision loss

doi: 10.1101/2025.05.14.653412 102 KashiwagiY.AburayaS.SugiyamaN.NarukawaY.SakamotoY.TakahashiM.et al

Numerous studies have found it to be well-tolerated, with very few reported side effects